Product Information

RIVASTIGMINE 6 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1806 per EA under NDC 62756014886. Its NADAC has been published 639 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RIVASTIGMINE 6 MG CAPSULE

Rivastigmine Tartrate
$0.1806per EA
High Outlier

Strength

6 mg/1

NDC

62756014886

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

2/18/2026

Active Ingredients

RIVASTIGMINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA077131

On Market Since

7/1/2010

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors

Price Statistics

The NADAC for RIVASTIGMINE 6 MG CAPSULE has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 90.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1806 per EA
All-time high$1.8897 (May 14, 2014)
All-time low$0.1548 (Jul 17, 2024)
52-week high$0.2384
52-week low$0.1759
Median price$0.3863
Average price$0.6665
Largest weekly change+65.7% (Nov 18, 2020)
Weeks tracked639
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+2.7%

1Y

-11.2%

3Y

-12.4%

5Y

-51.2%

All

-90.3%

Generic Alternatives

The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RIVASTIGMINE 6 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 6 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.1806 per EA (NDC 62756014886), effective Feb 18, 2026.

How has the price of RIVASTIGMINE 6 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RIVASTIGMINE 6 MG CAPSULE has declined 90.3%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 6 MG CAPSULE?

Since Nov 28, 2013, the NADAC for RIVASTIGMINE 6 MG CAPSULE has ranged from a low of $0.1548 (Jul 17, 2024) to a high of $1.8897 (May 14, 2014), with a median of $0.3863 per EA.

Are there cheaper alternatives to RIVASTIGMINE 6 MG CAPSULE?

Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 6 MG CAPSULE, is $0.1638 per EA — about 9% below RIVASTIGMINE 6 MG CAPSULE.

Who manufactures RIVASTIGMINE 6 MG CAPSULE?

RIVASTIGMINE 6 MG CAPSULE (NDC 62756014886) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.